Literature DB >> 33331317

[Association between CMTM5 gene and coronary artery disease and the relative mechanism].

T F Liu, T Lin, L H Ren, G P Li, J J Peng.   

Abstract

OBJECTIVE: To elucidate the correlation between CKLF-like MARVEL transmembrane domain containing member 5 (CMTM5) gene and the risk of coronary artery disease (CAD), and to detect the effects of CMTM5 gene expression changes on the ability of adhesion and migration of THP-1 cells.
METHODS: Using case-control method, a total of 700 hospitalized patients in Shijitan Hospital were enrolled in this study. CAD were diagnosed by coronary angiography, which was defined as at least one blood vessel diameter stenosis ≥50% according to the result of coronary angiography. Reverse transcription-polymerase chain reaction (RT-PCR) method was used to detect CMTM5 gene expression; enzyme linked immunosorbent assay (ELISA) method to detect the plasma level of CMTM5; and Logistic regression to analyze CMTM5 genes and the risk of CAD. Human vascular endothelial cells (ECs) and THP-1 cells were cultivated, adhesion and Transwells experiments were used to evaluate the chemotactic capabi-lity of CMTM5 gene on THP-1 cells.
RESULTS: In this study, 350 CAD patients matched with 350 control patients were included. RT-PCR results revealed CMTM5 mRNA expression in CAD group was 3.45 times compared with control group, which was significantly higher than that in control group (P < 0.05). The levels of CMTM5 plasma protein in CAD group was (206.1±26.9) μg/L, which was significantly higher than that in control group (125.3±15.2) μg/L (P < 0.05). After adjusted for the risk factors of age, gender, BMI, smoking, hypertension, diabetes and hyperlipidemia, Logistic regression analysis results indicated that CMTM5 was the susceptibility factors of CAD, which still had significant correlation with CAD (P < 0.05). Adhesion and Transwells experiments results revealed that the numbers of adhesion and migration of THP-1 cells in CMTM5 overexpression ECs group (EO group) were significantly higher than that in lenti-mock infected ECs group (EO-MOCK group), non-infected ECs group (EN group), lenti-mock infected ECs group (ES-MOCK group), and CMTM5 suppression ECs group (ES group). On the contrary, the numbers of adhesion and migration of THP-1 cells in ES group were significantly lower than that in the other four groups (P < 0.01).
CONCLUSION: CMTM5 gene was closely related to the development of CAD. CMTM5 overexpression promoted the adhesion and migration of THP-1, which might play a part in the mechanisms of atherosclerosis and CAD.

Entities:  

Keywords:  Atherosclerosis; CMTM5; Coronary artery disease; Gene

Mesh:

Substances:

Year:  2020        PMID: 33331317      PMCID: PMC7745279     

Source DB:  PubMed          Journal:  Beijing Da Xue Xue Bao Yi Xue Ban        ISSN: 1671-167X


  19 in total

1.  Association of V249I and T280M polymorphisms in the chemokine receptor CX3CR1 gene with early onset of coronary artery disease among North Indians.

Authors:  Neha Singh; Himanshu Rai; Nakul Sinha; Sudeep Kumar; Chandra M Pandey; Suraksha Agrawal
Journal:  Genet Test Mol Biomarkers       Date:  2012-06-25

Review 2.  Atherosclerosis: current pathogenesis and therapeutic options.

Authors:  Christian Weber; Heidi Noels
Journal:  Nat Med       Date:  2011-11-07       Impact factor: 53.440

Review 3.  The many roles of chemokines and chemokine receptors in inflammation.

Authors:  Israel F Charo; Richard M Ransohoff
Journal:  N Engl J Med       Date:  2006-02-09       Impact factor: 91.245

Review 4.  The chemokine system and CCR5 antagonists: potential in HIV treatment and other novel therapies.

Authors:  H Dhami; C E Fritz; B Gankin; S H Pak; W Yi; M-J Seya; R B Raffa; S Nagar
Journal:  J Clin Pharm Ther       Date:  2009-04       Impact factor: 2.512

5.  Aspirin exposure reveals novel genes associated with platelet function and cardiovascular events.

Authors:  Deepak Voora; Derek Cyr; Joseph Lucas; Jen-Tsan Chi; Jennifer Dungan; Timothy A McCaffrey; Richard Katz; L Kristin Newby; William E Kraus; Richard C Becker; Thomas L Ortel; Geoffrey S Ginsburg
Journal:  J Am Coll Cardiol       Date:  2013-07-03       Impact factor: 24.094

Review 6.  CC chemokines and protective immunity: insights gained from mother-to-child transmission of HIV.

Authors:  Caroline T Tiemessen; Louise Kuhn
Journal:  Nat Immunol       Date:  2007-03       Impact factor: 25.606

7.  Validation of aspirin response-related transcripts in patients with coronary artery disease and preliminary investigation on CMTM5 function.

Authors:  J W Zhang; T F Liu; X H Chen; W Y Liang; X R Feng; L Wang; Sidney W Fu; Timothy A McCaffrey; M L Liu
Journal:  Gene       Date:  2017-04-28       Impact factor: 3.688

Review 8.  Chemokines in the immunopathogenesis of hepatitis C infection.

Authors:  Mathis Heydtmann; David H Adams
Journal:  Hepatology       Date:  2009-02       Impact factor: 17.425

Review 9.  The specific role of chemokines in atherosclerosis.

Authors:  Vincent Braunersreuther; François Mach; Sabine Steffens
Journal:  Thromb Haemost       Date:  2007-05       Impact factor: 5.249

Review 10.  Chemokines: established and novel targets in atherosclerosis.

Authors:  Rory R Koenen; Christian Weber
Journal:  EMBO Mol Med       Date:  2011-10-28       Impact factor: 12.137

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.